MedTrace Logo

MR Guided Laser Interstitial Thermal Therapy for the "Minimal Invasive" Treatment of Brain Metastasis and Primary Brain Tumors

NCT00392119 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 18

Last updated 2010-01-01

No results posted yet for this study

Summary

The purpose of this study is to determine if the stereotactic, MR guided, laser interstitial thermal therapy treatment technique can be safety and efficiently used for human brain metastasis and primary brain tumors.

Conditions

Interventions

DEVICE

MR-guided Laser Interstitial Thermal Therapy System

Sponsors & Collaborators

  • BioTex, Inc.

    lead INDUSTRY

Principal Investigators

  • Alexandre Carpentier, M.D./ Ph.D. · Hospital Lariboisiere, Paris, France

  • Eric Vicaut, Ph.D. · Hospital Lariboisiere, Paris, France

  • Daniel Reizine, M.D. · Hospital Lariboisiere, Paris, France

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-10-31
Completion
2008-12-31

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00392119 on ClinicalTrials.gov